Azerbaijan vs Central African Republic: Pneumococcal conjugate second or third-dose vaccines (PCVc)

Azerbaijan
52.0%
in 2025
Central African Republic
45.0%
in 2025
Azerbaijan rank
155th
Central African Republic rank
158th

Pneumococcal conjugate second or third-dose vaccines (PCVc) over time

  • Azerbaijan
  • Central African Republic
020406080200820162025

How they compare

Azerbaijan currently reports 52.0% against 45.0% in Central African Republic, a difference of 7.0%.

That makes Azerbaijan's figure about 1.2 times Central African Republic's.

The two have swapped places 1 time across 18 shared years of data; in 2008 it was Central African Republic ahead.

Azerbaijan ranks 155th and Central African Republic ranks 158th of 194 countries.

Azerbaijan has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Azerbaijan Central African Republic Difference Ahead
2000s 0.0% 0.0% 0.0%
2010s 42.0% 32.7% 9.3% Azerbaijan
2020s 50.8% 38.0% 12.8% Azerbaijan

Averages of every year both report within each decade.

Frequently asked questions

Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Azerbaijan or Central African Republic?
Azerbaijan, at 52.0% against 45.0% in Central African Republic as of 2025.
What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Azerbaijan and Central African Republic?
7.0%, with Azerbaijan ahead.
How many years of comparable data are there for Azerbaijan and Central African Republic?
18 years are reported by both, from 2008 to 2025.
How do Azerbaijan and Central African Republic rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
Azerbaijan ranks 155th and Central African Republic ranks 158th of 194 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Azerbaijan vs Central African Republic: Pneumococcal conjugate second or third-dose vaccines (PCVc). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 23 August 2026, from https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/azerbaijan/central-african-republic/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/azerbaijan/central-african-republic/">Azerbaijan vs Central African Republic: Pneumococcal conjugate second or third-dose vaccines (PCVc)</a> — Statizoid

About this data

Indicator
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
206 places, 3,705 data points, 2008–2025
Last refreshed